NOBEL BIOCARE NORGE AS

1597 MOSS

Finances

Return on Equity

1,06 %

Current Ratio

0,54

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	32 429 000	34 083 000	27 173 000	27 899 000
Net Income	93 000	1 157 000	−561 000	1 050 000
Total Assets	29 940 000	30 125 000	26 284 000	28 868 000
Total Equity	8 796 000	8 703 000	7 546 000	8 107 000

Income (NOK)	2022	2021	2020	2019
Revenue	32 429 000	34 083 000	27 173 000	27 899 000
Expenditure	31 861 000	32 406 000	27 733 000	25 882 000
Operating Profit	568 000	1 677 000	−560 000	2 016 000
Financial Income	7 000	0	0	0
Financial Costs	449 000	193 000	300 000	664 000
Financial Balance	−442 000	−193 000	−300 000	−664 000
Earnings Before Tax	126 000	1 484 000	−860 000	1 353 000
Tax	34 000	327 000	−299 000	302 000
Net Income	93 000	1 157 000	−561 000	1 050 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	18 520 000	18 426 000	18 329 000	18 240 000
Total Current Assets	11 420 000	11 699 000	7 955 000	10 629 000
Total Assets	29 940 000	30 125 000	26 284 000	28 868 000
Total Retained Equity	8 696 000	8 603 000	7 446 000	8 007 000
Total Equity	8 796 000	8 703 000	7 546 000	8 107 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	21 145 000	21 422 000	18 738 000	20 762 000
Total Equity and Debt	29 940 000	30 125 000	26 284 000	28 868 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	32 429 000	34 083 000	27 173 000	27 899 000
Other Income	0	0	0	0
Revenue	32 429 000	34 083 000	27 173 000	27 899 000
Cost of Goods Sold	17 709 000	20 217 000	17 758 000	14 525 000
Salary Costs	9 582 000	8 381 000	7 235 000	7 022 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	31 861 000	32 406 000	27 733 000	25 882 000
Operating Profit	568 000	1 677 000	−560 000	2 016 000
Financial Income	7 000	0	0	0
Financial Costs	449 000	193 000	300 000	664 000
Financial Balance	−442 000	−193 000	−300 000	−664 000
Dividends	0	0	0	0
Net Income	93 000	1 157 000	−561 000	1 050 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	317 000	223 000	127 000	37 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	18 203 000	18 203 000	18 203 000	18 203 000
Total Fixed Assets	18 520 000	18 426 000	18 329 000	18 240 000
Stock	6 526 000	4 100 000	2 459 000	2 756 000
Total Investments	0	0	0	0
Cash, Bank	21 000	121 000	104 000	101 000
Total Current Assets	11 420 000	11 699 000	7 955 000	10 629 000
Total Assets	29 940 000	30 125 000	26 284 000	28 868 000
Total Equity	8 796 000	8 703 000	7 546 000	8 107 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	3 616 000	489 000	182 000	17 971 000
Unpaid Taxes	1 258 000	1 640 000	1 630 000	1 161 000
Dividends	0	0	0	0
Other Current Debt	1 892 000	1 769 000	1 593 000	1 409 000
Total Current Debt	21 145 000	21 422 000	18 738 000	20 762 000
Total Equity and Debt	29 940 000	30 125 000	26 284 000	28 868 000

Financial indicators	2022	2021	2020	2019
Return on Equity	1,06 %	13,29 %	−7,43 %	12,95 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	1,75 %	4,92 %	−2,06 %	7,23 %
Current Ratio	0,54	0,55	0,42	0,51
Quick Ratio	0,78	0,68	0,49	0,59
Equity Ratio	0,29	0,29	0,29	0,28
Gross Profit Margin	45,39 %	40,68 %	34,65 %	47,94 %